mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
8e-09 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
6e-08 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
9e-08 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-07 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-07 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-07 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-07 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
5e-07 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
6e-07 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
8e-07 |